Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Isabel Betancor-Fernández

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Revista Espanola De Enfermedades Digestivas|December 10, 2020
Mucinous cystadenoma arising from a pancreatic heterotopiaAntonio Z Gimeno-García, Sonia García-Hernández, Isabel Betancor-Fernández
Handbook of Experimental Pharmacology|October 11, 2017
Natural (and Unnatural) Small Molecules as Pharmacological Chaperones and Inhibitors in CancerIsabel Betancor-Fernández, David J Timson, Eduardo Salido, et al.
Genes|July 18, 2018
Evolutionary Divergent Suppressor Mutations in Conformational DiseasesNoel Mesa-Torres, Isabel Betancor-Fernández, Elisa Oppici, et al.
Advances in Protein Chemistry and Structural Biology|January 13, 2019
Structural and functional insights on the roles of molecular chaperones in the mistargeting and aggregation phenotypes associated with primary hyperoxaluria type IJosé Ángel Fernández-Higuero, Isabel Betancor-Fernández, Noel Mesa-Torres, et al.
Human Pathology|August 16, 2024
Association of both BCL2 positive and negative follicular lymphoma to clasical Hodgkin lymphoma and/or gray zone lymphomaFrancisco Javier Díaz de la Pinta, Rebeca Manso, Isabel Betancor Fernández, et al.
Journal of Personalized Medicine|May 28, 2022
Targeting HIF-1α Function in Cancer through the Chaperone Action of NQO1: Implications of Genetic Diversity of NQO1Eduardo Salido, David J Timson, Isabel Betancor-Fernández, et al.
Human Molecular Genetics|September 15, 2018
Insight into the specificity and severity of pathogenic mechanisms associated with missense mutations through experimental and structural perturbation analysesEncarnación Medina-Carmona, Isabel Betancor-Fernández, Jaime Santos, et al.
Oncogene|March 20, 2021
ARID2 deficiency promotes tumor progression and is associated with higher sensitivity to chemotherapy in lung cancerThaidy Moreno, Beatriz Monterde, Laura González-Silva, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Revista Espanola De Enfermedades Digestivas|December 10, 2020
Mucinous cystadenoma arising from a pancreatic heterotopiaAntonio Z Gimeno-García, Sonia García-Hernández, Isabel Betancor-Fernández
Handbook of Experimental Pharmacology|October 11, 2017
Natural (and Unnatural) Small Molecules as Pharmacological Chaperones and Inhibitors in CancerIsabel Betancor-Fernández, David J Timson, Eduardo Salido, et al.
Genes|July 18, 2018
Evolutionary Divergent Suppressor Mutations in Conformational DiseasesNoel Mesa-Torres, Isabel Betancor-Fernández, Elisa Oppici, et al.
Advances in Protein Chemistry and Structural Biology|January 13, 2019
Structural and functional insights on the roles of molecular chaperones in the mistargeting and aggregation phenotypes associated with primary hyperoxaluria type IJosé Ángel Fernández-Higuero, Isabel Betancor-Fernández, Noel Mesa-Torres, et al.
Human Pathology|August 16, 2024
Association of both BCL2 positive and negative follicular lymphoma to clasical Hodgkin lymphoma and/or gray zone lymphomaFrancisco Javier Díaz de la Pinta, Rebeca Manso, Isabel Betancor Fernández, et al.
Journal of Personalized Medicine|May 28, 2022
Targeting HIF-1α Function in Cancer through the Chaperone Action of NQO1: Implications of Genetic Diversity of NQO1Eduardo Salido, David J Timson, Isabel Betancor-Fernández, et al.
Human Molecular Genetics|September 15, 2018
Insight into the specificity and severity of pathogenic mechanisms associated with missense mutations through experimental and structural perturbation analysesEncarnación Medina-Carmona, Isabel Betancor-Fernández, Jaime Santos, et al.
Oncogene|March 20, 2021
ARID2 deficiency promotes tumor progression and is associated with higher sensitivity to chemotherapy in lung cancerThaidy Moreno, Beatriz Monterde, Laura González-Silva, et al.
Pageof 1